Patent Assignment
Reel/Frame 063123/0273
Change of Name
Recorded: 2023-03-21
Pages: 3
Assignor
CREALTA PHARMACEUTICALS LLC
Executed: 2016-01-13
Assignee
HORIZON PHARMA USA RHEUMATOLOGY LLC
150 S. SAUNDERS RD., SUITE 130, LAKE FOREST, ILLINOIS, 60045
Covered Property
(1)
Methods and Kits for Predicting Infusion Reaction Risk and Antibody-Mediated Loss of Response by Monitoring Serum Uric Acid During Pegylated Uricase Therapy
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 21, 2023
From: ROSARIO-JANSEN, THERESA; WRIGHT, DAVID ERICK
To: SAVIENT PHARMACEUTICALS, INC.
Reel/Frame 063050/0097 →
Assignment of Assignor's Interest
Mar 21, 2023
From: HORIZON PHARMA RHEUMATOLOGY LLC
To: HORIZON THERAPEUTICS USA, INC.
Reel/Frame 063124/0305 →
Assignment of Assignor's Interest
Mar 21, 2023
From: SAVIENT PHARMACEUTICALS, INC.; SAVIENT PHARMA HOLDINGS, INC.
To: CREALTA PHARMACEUTICALS LLC
Reel/Frame 063124/0342 →
Change of Name
Mar 21, 2023
From: HORIZON PHARMA USA RHEUMATOLOGY LLC
To: HORIZON PHARMA RHEUMATOLOGY LLC
Reel/Frame 064464/0900 →